Meetings with the leadership and review staff of the US Food and
Drug Administration (FDA) are one of the most important resources
available to sponsors seeking agency approval in the US. PharmaLex
recommends holding face-to-face and teleconference meetings with
FDA throughout the product development timeline.

Download